27-Dec-15 Japanese health monitor maker Omron Healthcare is looking at more than doubling its revenues in India to USD40 mn by 2018/19, on the back of sales network expansion. The company, which is expecting sales of USD19 mn this year, is also open to the idea of opening a factory in India depending on the demand of its products. [image: Ormon Healthcare].

16-Dec-15 Singapore-based Parkway Pantai, one of Asia's largest healthcare providers, is planning huge healthcare capacities in India, challenging leaders like Apollo and Fortis. Parkway, owned by the Malaysian sovereign fund-backed IHH Healthcare, is planning to add up to 5,000 beds in the next two years, half of this in India, said Dr Tan See Leng, managing director of Parkway and IHH. [image: Business Today]

15-Dec-15 Despite recording gains in recent years, India continues to lag several health indicators such as mortality rates and malnutrition. A paper in The Lancet identifies seven structural problems: 1. A weak primary healthcare; 2. Unequally distributed human resources; 3. Large unregulated private sector; 4. Low public spending; 5. Fragmented information systems; 6. Irrational drug use and spiralling cost; 7. Weak governance and accountability. [image: Hindustan Times]

11-Dec-15 India’s Ministry of Health & Family Welfare (MOHFW) and the Central Drugs Standard Control Organization (CDSCO) have met with medical device association representatives to discuss how the country can become a hub for device manufacturing and begin to align with global regulations. The discussion centered on increasing device exports and evaluating new guidance for the industry. [image: RAPS]

10-Dec-15 US-based healthcare IT firm eClinicalWorks will invest USD30 mn as part of its expansion plans for the digital healthcare market in India. The investment will focus on developing cloud-based technology infrastructure, the company said. eClinicalWorks has said tele-health capabilities allow patients to access their doctors via mobile phones and enable them to immediately address medical concerns. [image: Reuters]